Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status. (Q53223661)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 May 2011
edit
Language Label Description Also known as
English
Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status.
scientific article published on 21 May 2011

    Statements

    Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit